Lyons-Williams Lori
Insider CIK 1693564 · FPRX Director · DERM Chief Commercial Officer · RAPT Director · CTNM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics, In | A Award deriv | 2026-06-26 | 2026-06-26 | 19,000 | — | $0 | 19,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 32,229 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 2,813 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,063 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,618 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 4,561 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | U Tender | 2026-03-03 | 2026-03-05 | 4,956 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award | 2026-01-30 | 2026-02-02 | 4,956 | — | $0 | 4,956 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2025-06-26 | 2025-06-26 | 14,750 | — | $0 | 14,750 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 257,832 | — | $0 | 257,832 | SEC↗ |
| CTNM Contineum Therapeutics, In | A Award deriv | 2024-05-24 | 2024-05-29 | 29,500 | — | $0 | 29,500 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2024-05-22 | 2024-05-23 | 36,490 | — | $0 | 36,490 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2023-05-25 | 12,940 | — | $0 | 12,940 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2022-05-25 | 2022-05-26 | 8,500 | — | $0 | 8,500 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2021-11-09 | 2021-11-10 | 22,500 | — | $0 | 22,500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 20,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 25,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-05-14 | 2020-05-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 100,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 6,378 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 65,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 63,750 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 15,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 30,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer | 2020-02-20 | 2020-02-24 | 25,401 | $18.75 | $476.3K | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-08-15 | 2019-08-19 | 3,189 | — | $0 | 6,378 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2019-08-15 | 2019-08-19 | 1,582 | $7.91 | $12.5K | 25,401 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-08-15 | 2019-08-19 | 3,189 | — | $0 | 26,983 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2019-06-23 | 2019-06-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-05-17 | 2019-05-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-05-17 | 2019-05-21 | 30,000 | — | $0 | 34,168 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2019-05-17 | 2019-05-21 | 10,374 | $10.50 | $108.9K | 23,794 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-02-12 | 2019-02-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-02-12 | 2019-02-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-08-15 | 2018-08-17 | 60,000 | — | $0 | 60,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2018-08-15 | 2018-08-17 | 1,063 | — | $0 | 9,567 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2018-08-15 | 2018-08-17 | 368 | $9.58 | $3.5K | 2,616 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2018-08-15 | 2018-08-17 | 1,063 | — | $0 | 2,984 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-02-15 | 2018-02-16 | 63,750 | $28.25 | $1.80M | 63,750 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-02-15 | 2018-02-16 | 10,630 | — | $0 | 10,630 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2017-01-09 | 2017-01-10 | 100,000 | — | $0 | 100,000 | SEC↗ |